Press Releases about Takeda Pharmaceutical Ltd ADR
![](https://mms.businesswire.com/media/20211027005677/en/920369/5/GammaDelta_logo_large.jpg)
![](https://mms.businesswire.com/media/20211013005074/en/914910/4/BioLife_logo.jpg)
![](https://mms.businesswire.com/media/20211007006064/en/914421/5/Dakiyama_2021_Takeda_Red_DIGITAL.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/812156/thumbnail-812156_0000.png)
![](https://mms.businesswire.com/media/20211005006237/en/913504/5/Dakiyama_2021_Takeda_Red_DIGITAL_%281%29.jpg)
Takeda Provides Update on TAK-994 Clinical Program
October 05, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210930005353/en/911427/4/JCR.jpg)
![](https://mms.businesswire.com/media/20210922005634/en/908603/5/Dakiyama_2021_Takeda_Red_DIGITAL_USE.jpg)
![](https://mms.businesswire.com/media/20210921005502/en/908173/4/Takeda_logo.jpg)
![](https://mms.businesswire.com/media/20210915006101/en/822613/5/takeda_logo.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/800521/thumbnail-800521_0000.png)
![](https://mms.businesswire.com/media/20210901005908/en/822613/5/takeda_logo.jpg)
Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
September 01, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210818005128/en/900102/4/BioLife_logo.jpg)
![](https://mms.businesswire.com/media/20210805005209/en/731159/5/TakedaBrandSymbol_Dakiyama_Rd.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20210801005052/en/791321/5/logo.jpg)
![](https://mms.businesswire.com/media/20210729006282/en/791321/5/logo.jpg)
![](https://mms.businesswire.com/media/20210729005286/en/894848/5/Hillevax_RGB_Horizontal-01.jpg)
![](https://mms.businesswire.com/media/20210728005256/en/794310/5/TakedaBrandSymbol_Dakiyama_Rd.jpg)
![](https://mms.businesswire.com/media/20210720005119/en/731159/5/TakedaBrandSymbol_Dakiyama_Rd.jpg)
![](https://mms.businesswire.com/media/20210719005332/en/791321/5/logo.jpg)
![](https://mms.businesswire.com/media/20210710005018/en/890243/5/TakedaBrandSymbol_Dakiyama_Rd_highres.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20210629005633/en/888227/5/Takeda_Logo.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/800426/thumbnail-800426_0011.png)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/800331/thumbnail-800331_0005.png)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/800141/thumbnail-800141_0009.png)
![](https://mms.businesswire.com/media/20210607005092/en/796084/5/TakedaBrandSymbol_Dakiyama_Rd.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20210522005005/en/834514/4/takeda_logo.jpg)
![](https://mms.businesswire.com/media/20210521005134/en/731159/5/TakedaBrandSymbol_Dakiyama_Rd.jpg)
![](https://mms.businesswire.com/media/20210520006154/en/880126/5/Takeda_Logo_Hi_Res.jpg)
![](https://mms.businesswire.com/media/20210519005913/en/822613/5/takeda_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.